$-0.05 EPS Expected for I.D. Systems, Inc. (IDSY); 3 Analysts Covering…


I.D. Systems, Inc. (NASDAQ:IDSY) Logo

Among 3 analysts covering Arrowhead Pharmaceuticals (NASDAQ:ARWR), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Arrowhead Pharmaceuticals had 3 analyst reports since September 6, 2018 according to SRatingsIntel. The stock of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has “Buy” rating given on Thursday, September 6 by Chardan Capital Markets. The rating was maintained by Cantor Fitzgerald on Monday, December 17 with “Overweight”. The firm has “Buy” rating by FBR Capital given on Thursday, September 6. See Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) latest ratings:

17/12/2018 Broker: Cantor Fitzgerald Old Rating: Overweight New Rating: Overweight Old Target: $145 New Target: $165 Maintain
06/09/2018 Broker: Chardan Capital Markets Old Rating: Buy New Rating: Buy Old Target: $17.5 New Target: $24.5 Maintain
06/09/2018 Broker: FBR Capital Old Rating: Neutral New Rating: Buy Old Target: $18 Upgrade

Analysts expect I.D. Systems, Inc. (NASDAQ:IDSY) to report $-0.05 EPS on March, 7.They anticipate $0.01 EPS change or 25.00% from last quarter’s $-0.04 EPS. After having $-0.05 EPS previously, I.D. Systems, Inc.’s analysts see 0.00% EPS growth. The stock decreased 0.31% or $0.02 during the last trading session, reaching $6.4. About 7,096 shares traded. I.D. Systems, Inc. (NASDAQ:IDSY) has declined 16.45% since February 14, 2018 and is downtrending. It has underperformed by 16.45% the S&P500. Some Historical IDSY News: 05/04/2018 – Hitachi ID Systems Showcases Password and Identity Management Solutions at the 2018 HDI Annual Conference; 29/03/2018 – l.D. Systems Announces Industrial Truck Telematics Technician Certification Program: IDSY University; 18/05/2018 – I.D. Systems Sets May 2018 Financial Conference Schedule; 07/03/2018 – Hitachi ID Systems is Positioned in Gartner’s 2018 Magic Quadrant for Identity Governance and Administration; 07/03/2018 Hitachi ID Systems is Positioned in Gartner’s 2018 Magic Quadrant for Identity Governance and Administration; 29/03/2018 – I.D. Systems Announces Industrial Truck Telematics Technician Certification Program: IDSY University; 21/04/2018 – DJ ID Systems Inc, Inst Holders, 1Q 2018 (IDSY); 18/05/2018 – l.D. Systems Sets May 2018 Financial Conference Schedule; 02/05/2018 – ID Systems 1Q Rev $13.4M; 12/03/2018 – I.D. Systems Introduces New Industrial Truck Telematics Solution Aimed at Small & Medium Sized Manufacturing, Distribution, &

Arrowhead Pharmaceuticals, Inc. develops novel drugs to treat intractable diseases in the United States. The company has market cap of $1.66 billion. The Company’s pre-clinical stage drug candidates include ARO-HBV to treat chronic hepatitis B virus infection; ARO-AAT to treat liver disease associated with alpha-1 antitrypsin deficiency; ARO-LPA to reduce production of apolipoprotein A; ARO-AMG1, which is developed against an undisclosed genetically validated cardiovascular target; and ARO-F12, a potential treatment for factor 12 mediated diseases, such as hereditary angioedema and thromboembolic disorders. It currently has negative earnings. The firm also develops ARO-HIF2, a drug candidate for the treatment of clear cell renal cell carcinoma.

More notable recent Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) news were published by: Nasdaq.com which released: “ARWR Makes Notable Cross Below Critical Moving Average – Nasdaq” on January 22, 2019, also Nasdaq.com with their article: “Report: Exploring Fundamental Drivers Behind TD Ameritrade Holding, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, Nucor, Portland General Electric, and TrueBlue — New Horizons, Emerging Trends, and Upcoming Developments – Nasdaq” published on January 31, 2019, Benzinga.com published: “66 Biggest Movers From Friday – Benzinga” on February 11, 2019. More interesting news about Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) were released by: Investorplace.com and their article: “5 Hot Small-Cap Stocks That Are a Bit Too Toasty – Investorplace.com” published on January 22, 2019 as well as Benzinga.com‘s news article titled: “The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings, IPOs (Feb. 3-9) – Benzinga” with publication date: February 03, 2019.

The stock increased 2.20% or $0.38 during the last trading session, reaching $17.66. About 714,019 shares traded. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has risen 279.44% since February 14, 2018 and is uptrending. It has outperformed by 279.44% the S&P500. Some Historical ARWR News: 15/05/2018 – Nexthera Capital Buys New 1.3% Position in Arrowhead Pharma; 30/05/2018 – Arrowhead’s ARO-HBV Is Being Developed as a Therapy for Patients With Chronic Hepatitis B Virus; 21/05/2018 – Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis; 24/04/2018 – Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results; 27/03/2018 – Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B; 11/05/2018 – Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline; 14/05/2018 – ARROWHEAD DOSES FIRST HEPATITIS B PATIENTS IN MULTIPLE DOSE; 20/03/2018 – Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4); 12/03/2018 – ARROWHEAD BEGINS DOSING IN PHASE 1 ARO-AAT LIVER DISEASE STUDY; 09/04/2018 – Prodware broadens its analyst coverage with Arrowhead

More notable recent I.D. Systems, Inc. (NASDAQ:IDSY) news were published by: Nasdaq.com which released: “ID Systems’ LV Series Platform Selected as a Heavy Duty Trucking Magazine Top 20 Product for 2018 – Nasdaq” on February 14, 2019, also Globenewswire.com with their article: “I.D. Systems and Jungheinrich AG Sign Global Technology Agreement – GlobeNewswire” published on February 07, 2019, Nasdaq.com published: “ID Systems to Present at the 21st Annual Needham Growth Conference on January 16, 2019 – Nasdaq” on January 11, 2019. More interesting news about I.D. Systems, Inc. (NASDAQ:IDSY) were released by: Nasdaq.com and their article: “TMUS vs. IDSY: Which Stock Is the Better Value Option? – Nasdaq” published on October 08, 2018 as well as Globenewswire.com‘s news article titled: “New I.D. Systems Product Line Transforms Logistics Visibility – GlobeNewswire” with publication date: October 29, 2018.

I.D. Systems, Inc. develops, markets, and sells wireless machine-to-machine solutions in the United States and internationally. The company has market cap of $115.87 million. The firm offers integrated wireless solutions that utilize radio frequency identification, Wi-Fi, satellite or cellular communications, sensor technologies, and software to control, track, monitor, and analyze industrial vehicles, rental vehicles, and transportation assets. It currently has negative earnings. It provides industrial and rental fleet asset management products, including on-asset hardware with mounting and user-interface options that provide an autonomous means of asset control and monitoring; wireless asset managers that link the mobile assets being monitored with the customer’s computer network or to a remotely hosted server; server software, which manages data communications between the system’s database and wireless asset managers or on-asset hardware; and client software.

Investors sentiment increased to 1.3 in Q3 2018. Its up 0.47, from 0.83 in 2018Q2. It is positive, as 2 investors sold I.D. Systems, Inc. shares while 8 reduced holdings. 4 funds opened positions while 9 raised stakes. 6.46 million shares or 1.31% less from 6.54 million shares in 2018Q2 were reported. Price T Rowe Md holds 0% of its portfolio in I.D. Systems, Inc. (NASDAQ:IDSY) for 10,800 shares. Bard Assocs Inc has 0.39% invested in I.D. Systems, Inc. (NASDAQ:IDSY) for 122,555 shares. Deutsche Natl Bank Ag owns 0% invested in I.D. Systems, Inc. (NASDAQ:IDSY) for 10,182 shares. California Employees Retirement holds 38,786 shares. Savings Bank Of America De accumulated 3,559 shares or 0% of the stock. Blackrock Inc owns 402,418 shares. Barclays Pcl accumulated 1,031 shares. Vanguard Grp Inc holds 0% or 616,902 shares in its portfolio. Archon Mngmt Limited Company reported 1.08 million shares. Moreover, Wells Fargo Mn has 0% invested in I.D. Systems, Inc. (NASDAQ:IDSY). Prentiss Smith & has 100 shares for 0% of their portfolio. Renaissance Techs Llc holds 0% or 219,597 shares in its portfolio. Susquehanna Group Inc Ltd Liability Partnership reported 0% in I.D. Systems, Inc. (NASDAQ:IDSY). Moreover, Victory Cap Mgmt has 0.01% invested in I.D. Systems, Inc. (NASDAQ:IDSY) for 353,097 shares. Ack Asset Mngmt Lc holds 11,434 shares or 0.02% of its portfolio.

I.D. Systems, Inc. (NASDAQ:IDSY) Institutional Positions Chart



Source link Google News

Add Comment